Jinwu Peng

1.1k total citations
50 papers, 792 citations indexed

About

Jinwu Peng is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jinwu Peng has authored 50 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 19 papers in Cancer Research and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jinwu Peng's work include Ferroptosis and cancer prognosis (12 papers), RNA modifications and cancer (10 papers) and Extracellular vesicles in disease (8 papers). Jinwu Peng is often cited by papers focused on Ferroptosis and cancer prognosis (12 papers), RNA modifications and cancer (10 papers) and Extracellular vesicles in disease (8 papers). Jinwu Peng collaborates with scholars based in China, United States and Saudi Arabia. Jinwu Peng's co-authors include Lifang Yang, Zhuan Zhou, Xia Wu, Yuanliang Yan, Dan Li, Zhijie Xu, San Xu, Chaoliang Liao, Bo Li and Xi Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Annals of Oncology.

In The Last Decade

Jinwu Peng

47 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinwu Peng China 16 490 335 203 194 95 50 792
Zhenqing Ye United States 12 455 0.9× 257 0.8× 227 1.1× 247 1.3× 212 2.2× 18 861
Wensheng Qiu China 17 518 1.1× 271 0.8× 215 1.1× 162 0.8× 62 0.7× 71 842
Jin He China 16 570 1.2× 356 1.1× 167 0.8× 98 0.5× 62 0.7× 47 907
Xiaoan Tao China 17 485 1.0× 349 1.0× 209 1.0× 82 0.4× 182 1.9× 41 977
Haishan Zhao China 17 527 1.1× 305 0.9× 300 1.5× 74 0.4× 62 0.7× 31 790
Qi‐Nian Wu China 17 724 1.5× 468 1.4× 240 1.2× 219 1.1× 148 1.6× 33 1.1k
Xiangyu Che China 18 489 1.0× 256 0.8× 155 0.8× 211 1.1× 96 1.0× 46 905
Yingying Liang China 15 426 0.9× 252 0.8× 341 1.7× 187 1.0× 170 1.8× 29 851
Xiuming Liang China 17 618 1.3× 356 1.1× 143 0.7× 292 1.5× 102 1.1× 22 914

Countries citing papers authored by Jinwu Peng

Since Specialization
Citations

This map shows the geographic impact of Jinwu Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinwu Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinwu Peng more than expected).

Fields of papers citing papers by Jinwu Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinwu Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinwu Peng. The network helps show where Jinwu Peng may publish in the future.

Co-authorship network of co-authors of Jinwu Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Jinwu Peng. A scholar is included among the top collaborators of Jinwu Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinwu Peng. Jinwu Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Xiaocheng, Jinwu Peng, Wei Zhu, et al.. (2025). FVTF inhibits hepatocellular carcinoma stem properties via targeting DNMT1/miR-34a-5p/FoxM1 axis. Chinese Medicine. 20(1). 32–32. 1 indexed citations
3.
Liu, Qiao, Jinwu Peng, Tao Zhang, et al.. (2025). Cloning and functional characterization of sesquiterpene synthase genes from Inonotus obliquus using a Saccharomyces cerevisiae expression system. World Journal of Microbiology and Biotechnology. 41(2). 56–56. 1 indexed citations
4.
Tang, Juan, Wei Zhu, Wei Huang, et al.. (2025). USP5 Binds and Stabilizes EphA2 to Increase Nasopharyngeal Carcinoma Radioresistance. International Journal of Biological Sciences. 21(3). 893–909.
5.
Zhou, Peijun, Lixin Chen, Min Tang, et al.. (2025). Deacetylation of TALDO1 by HDAC6 promotes glycolysis and nasopharyngeal carcinoma progression through a moonlighting function. Cell Death and Disease. 16(1). 743–743.
6.
Peng, Jinwu, et al.. (2023). A combined analysis of multi-omics data reveals the prognostic values and immunotherapy response of LAG3 in human cancers. European journal of medical research. 28(1). 604–604. 3 indexed citations
7.
Ning, Yue, Hongmei Zheng, Yang Yang, et al.. (2023). YAP1 synergize with YY1 transcriptional co-repress DUSP1 to induce osimertinib resistant by activating the EGFR/MAPK pathway and abrogating autophagy in non-small cell lung cancer. International Journal of Biological Sciences. 19(8). 2458–2474. 18 indexed citations
8.
Thakur, Abhimanyu, et al.. (2023). Multi-omics analysis of DNA replication-associated primase polymerase (PRIMPOL) in pan-cancer: a potential target for prognosis and immune response. European journal of medical research. 28(1). 207–207. 3 indexed citations
9.
Yan, Yuanliang, Yuan Cai, Qiuju Liang, et al.. (2022). Identification of m6A-Associated Gene DST as a Prognostic and Immune-Associated Biomarker in Breast Cancer Patients. SHILAP Revista de lepidopterología. 5 indexed citations
10.
Yi, Qiaoli, Jinwu Peng, Zhijie Xu, et al.. (2022). Spectrum of BRAF Aberrations and Its Potential Clinical Implications: Insights From Integrative Pan-Cancer Analysis. Frontiers in Bioengineering and Biotechnology. 10. 806851–806851. 9 indexed citations
11.
Lu, Can, Xi Chen, Yuanliang Yan, et al.. (2022). Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Glioblastoma. Frontiers in Pharmacology. 13. 768743–768743. 8 indexed citations
13.
Peng, Bi, et al.. (2022). Ferroptosis-Related Gene MT1G as a Novel Biomarker Correlated With Prognosis and Immune Infiltration in Colorectal Cancer. Frontiers in Cell and Developmental Biology. 10. 881447–881447. 20 indexed citations
14.
Liang, Qiuju, Jinwu Peng, Zhijie Xu, et al.. (2022). Pan-cancer analysis of the prognosis and immunological role of AKAP12: A potential biomarker for resistance to anti-VEGF inhibitors. Frontiers in Genetics. 13. 943006–943006. 17 indexed citations
15.
Xu, Zhijie, Bi Peng, Jianbo Li, et al.. (2022). The Roles of Drug Metabolism-Related ADH1B in Immune Regulation and Therapeutic Response of Ovarian Cancer. Frontiers in Cell and Developmental Biology. 10. 877254–877254. 12 indexed citations
16.
Yan, Yuanliang, Jinwu Peng, Abhimanyu Thakur, et al.. (2022). Decoding Roles of Exosomal lncRNAs in Tumor-Immune Regulation and Therapeutic Potential. Cancers. 15(1). 286–286. 38 indexed citations
17.
Liu, Liyu, et al.. (2020). ADAM17 promotes the invasion of hepatocellular carcinoma via upregulation MMP21. Cancer Cell International. 20(1). 516–516. 11 indexed citations
18.
Wu, Xia, Zhuan Zhou, San Xu, et al.. (2020). Extracellular vesicle packaged LMP1-activated fibroblasts promote tumor progression via autophagy and stroma-tumor metabolism coupling. Cancer Letters. 478. 93–106. 113 indexed citations
19.
Zhang, H., Hongbin Lü, Yun‐Zhi Feng, et al.. (2015). In Serum, Higher Parathyroid Hormone but Not Lower Vitamin D Is Associated with Oral Squamous Cell Carcinoma. Current Oncology. 22(4). 259–263. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026